{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:04Z","timestamp":1793314864480,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Historically, the elderly population was underrepresented in clinical trials evaluating the optimal treatment for non-ST-segment elevation myocardial infarction (NSTEMI). Therefore, we aimed to compare invasive versus noninvasive strategies for the management of NSTEMI in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, SCOPUS, and Cochrane Central Register of Controlled Trials were screened for studies evaluating medical therapy or invasive revascularization in elderly patients with NSTEMI. Following outcomes were extracted: all-cause mortality, cardiovascular death, fatal or nonfatal MI, repeat coronary revascularization, major adverse cardiovascular events (MACE), bleeding, stroke, noncardiovascular death, and repeat hospitalization for heart failure. Data were pooled using random-effects model to evaluate weighted mean differences and risk ratios with 95% confidence intervals (CIs). This study is registered with PROSPERO, CRD42024622236.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven studies (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2005=\u20052997 patients) were included. Patients treated with medical versus invasive therapies showed no significant difference in all-cause mortality (risk ratio: 1.05, 95% CI: 0.94\u20131.18,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.37); however, invasive therapies significantly decreased the risk of fatal or nonfatal MI (risk ratio: 0.75, 95% CI: 0.59\u20130.96,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.02), repeat coronary revascularizations (risk ratio: 0.29, 95% CI: 0.21\u20130.40,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.00001), and risk of MACE (risk ratio: 0.74, 95% CI: 0.61\u20130.89,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.002). Lastly, invasive therapies were associated with increased risk of bleeding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Invasive therapy, in comparison to medical management, has reduced incidence of fatal or nonfatal MI, MACE, and the need for revascularization; however, no benefit was noted for all-cause and cardiovascular mortality. Age-specific guidelines must be established for the management of NSTEMI among older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001586","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:00:09Z","timestamp":1762070409000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of invasive versus noninvasive treatments in elderly patients with non-ST-segment myocardial infarction: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"37","author":[{"given":"Shanza","family":"Malik","sequence":"first","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Quettawala","family":"Mufaddal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Koskina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medstar Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Mustafa","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mansour","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medstar Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Nusrat","sequence":"additional","affiliation":[{"name":"Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafay","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umer","family":"Sohail","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Husain","family":"Farhan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medstar Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaque","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medstar Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/CRD.0000000000000016","article-title":"Acute coronary syndrome among older patients: a review.","volume":"23","author":"Veerasamy","year":"2015","journal-title":"Cardiol Rev"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"oeab044","DOI":"10.1093\/ehjopen\/oeab044","article-title":"Is the contemporary care of the older persons with acute coronary syndrome evidence-based?","volume":"2","author":"Mills","year":"2022","journal-title":"Eur Heart J Open"},{"key":"R3-20260327","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(20)30930-2","article-title":"Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data.","volume":"396","author":"Kaura","year":"2020","journal-title":"Lancet"},{"key":"R5-20260327","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamacardio.2020.0359","article-title":"Enrollment of older patients, women, and racial\/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review.","volume":"5","author":"Tahhan","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/eurheartj\/ehae151","article-title":"Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.","volume":"45","author":"Kotanidis","year":"2024","journal-title":"Eur Heart J"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(15)01166-6","article-title":"Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomized controlled trial.","volume":"387","author":"Tegn","year":"2016","journal-title":"Lancet"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa2407791","article-title":"Invasive treatment strategy for older patients with myocardial infarction.","volume":"391","author":"Kunadian","year":"2024","journal-title":"NEJM"},{"key":"R9-20260327","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R10-20260327","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R11-20260327","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamainternmed.2023.0047","article-title":"Effect of routine invasive vs conservative strategy in older adults with frailty and non-ST-segment elevation acute myocardial infarction: a randomized clinical trial.","volume":"183","author":"Sanchis","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4244\/EIJ-D-20-00975","article-title":"Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial.","volume":"17","author":"de Belder","year":"2021","journal-title":"EuroIntervention"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14017431.2020.1781243","article-title":"Percutaneous coronary intervention in the very elderly with NSTE-ACS: the randomized 80+ study.","volume":"54","author":"Hirlekar","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2016.07.003","article-title":"Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction.","volume":"35","author":"Sanchis","year":"2016","journal-title":"Eur J Intern Med"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jcin.2012.06.008","article-title":"Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.","volume":"5","author":"Savonitto","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"e036151","DOI":"10.1161\/JAHA.124.036151","article-title":"Invasive versus conservative strategy in older adults \u226575 years of age with non-ST\u2010segment-elevation acute coronary syndrome: a systematic review and meta\u2010analysis of randomized controlled trials.","volume":"13","author":"Rout","year":"2024","journal-title":"JAHA"},{"key":"R17-20260327","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-025-04560-8","article-title":"Invasive versus conservative strategies for non-ST-elevation acute coronary syndrome in the elderly: an updated systematic review and meta-analysis of randomized controlled trials.","volume":"25","author":"Kohansal","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"R18-20260327","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(16)31276-4","article-title":"Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15-year follow-up of a prospective, randomised, multicentre study.","volume":"388","author":"Wallentin","year":"2016","journal-title":"Lancet"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of Unstable Angina.","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"R20-20260327","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"R21-20260327","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban.","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-20260327","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2300468","article-title":"Complete or culprit-only PCI in older patients with myocardial infarction.","volume":"389","author":"Biscaglia","year":"2023","journal-title":"N Engl J Med"},{"key":"R23-20260327","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2012.10.032","article-title":"The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011).","volume":"61","author":"Baklanov","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260327","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/eurheartj\/ehab468","article-title":"Frailty and cardiovascular outcomes in the National Health and Aging Trends Study.","volume":"42","author":"Damluji","year":"2021","journal-title":"Eur Heart J"},{"key":"R25-20260327","first-page":"166","article-title":"Frailty and acute coronary syndrome: a structured literature review.","volume":"7","author":"Bebb","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:00:14Z","timestamp":1774594814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001586","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"2025-03-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}